Compare HROW & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | HROW | JJSF |
|---|---|---|
| Founded | 1998 | 1971 |
| Country | United States | United States |
| Employees | N/A | 1800 |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2008 | 1995 |
| Metric | HROW | JJSF |
|---|---|---|
| Price | $30.61 | $77.58 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $65.00 | ★ $110.50 |
| AVG Volume (30 Days) | ★ 486.5K | 135.0K |
| Earning Date | 11-09-2026 | 11-16-2026 |
| Dividend Yield | N/A | ★ 4.19% |
| EPS Growth | ★ 71.43 | N/A |
| EPS | N/A | ★ 1.99 |
| Revenue | N/A | ★ $1,022,038,000.00 |
| Revenue This Year | $28.81 | N/A |
| Revenue Next Year | $53.97 | $1.98 |
| P/E Ratio | ★ N/A | $38.98 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $28.54 | $68.87 |
| 52 Week High | $54.98 | $98.63 |
| Indicator | HROW | JJSF |
|---|---|---|
| Relative Strength Index (RSI) | 27.10 | 31.23 |
| Support Level | $28.54 | $73.60 |
| Resistance Level | $35.43 | $78.56 |
| Average True Range (ATR) | 1.25 | 1.63 |
| MACD | -0.21 | -0.31 |
| Stochastic Oscillator | 11.48 | 3.41 |
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.
J&J Snack Foods Corp. manufactures snack foods and distributes frozen beverages, which it markets nationally to the foodservice and retail supermarket industries. The company's portfolio of frozen beverages, frozen novelties, and baked goods includes soft pretzels, frozen juice treats and desserts, stuffed sandwiches, churros, funnel cakes, cookies, and other snack foods and drinks. It operates through three segments: Food Service, which sells snacks, desserts, and baked goods at the point of sale; Retail Supermarkets, which sells frozen and prepackaged products to supermarkets; and Frozen Beverages, which sells frozen beverages under the ICEE, Slush Puppie, and Parrot Ice brands in the United States, Mexico, and Canada. The majority of revenue comes from the Food Service segment.